HOOKIPA Pharma Inc. (HOOK)
USD 2.0
(-6.1%)
USD 2.0
(-6.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 20.12 Million | 14.24 Million | 18.44 Million | 19.58 Million | 11.94 Million | 7.62 Million |
| Cost of Revenue | 3.55 Million | 3.6 Million | 4.64 Million | 53.13 Million | 46.31 Million | 21.96 Million |
| Gross Profit | 16.57 Million | 10.64 Million | 13.8 Million | -33.54 Million | -34.37 Million | -14.33 Million |
| Operating Expenses | 32.74 Million | 87.4 Million | 100.12 Million | 72.86 Million | 63.02 Million | 23.19 Million |
| Selling, General and Administrative Expenses | 18.63 Million | 18.75 Million | 17.26 Million | 18.08 Million | 16.71 Million | 6.84 Million |
| Research and Development Expenses | 86.42 Million | 68.64 Million | 82.85 Million | 54.78 Million | 46.31 Million | 21.96 Million |
| Other Expenses | - | -392 Thousand | -2.84 Million | 3.07 Million | 601 Thousand | 133 Thousand |
| Cost and Expenses | 117.82 Million | 87.4 Million | 100.12 Million | 72.86 Million | 63.02 Million | 23.19 Million |
| Operating Income | -97.69 Million | -73.15 Million | -81.67 Million | -53.28 Million | -51.08 Million | -21.18 Million |
| Interest Expense | 317 Thousand | 687 Thousand | 898 Thousand | 786 Thousand | 877 Thousand | 778 Thousand |
| Income Tax Expense | 368 Thousand | 230 Thousand | 1000.00 | -10.28 Million | -8.89 Million | 24 Thousand |
| Earnings before Tax | -81.21 Million | -64.91 Million | -75.66 Million | -44.08 Million | -43.03 Million | -16.21 Million |
| Net Income | -81.58 Million | -64.91 Million | -75.66 Million | -44.08 Million | -43.03 Million | -16.23 Million |
| Earnings Per Share Basic | -8.63 | -9.90 | -23.00 | -16.90 | -2.41 | -0.99 |
| Earnings Per Share Diluted | -8.63 | -9.90 | -23.00 | -16.90 | -2.41 | -0.99 |
| Weighted Average Shares Outstanding | 9.45 Million | 6.55 Million | 3.28 Million | 2.6 Million | 17.85 Million | 16.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.45 Million | 6.55 Million | 3.28 Million | 2.6 Million | 17.85 Million | 16.32 Million |
| Gross Margin | 0.82 | 0.75 | 0.75 | -1.71 | -2.88 | -1.88 |
| EBIT Margin | -3.84 | -5.13 | -4.43 | -2.72 | -4.28 | -1.94 |
| Profit Margin | -4.05 | -4.56 | -4.10 | -2.25 | -3.60 | -2.13 |
| EBITDA | -77.34 Million | -60.39 Million | -70.12 Million | -39.14 Million | -39.09 Million | -14.79 Million |
| Earnings Before Tax Margin | -4.85 | -5.13 | -4.43 | -2.72 | -4.28 | -2.78 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.29 Million | 36.59 Million | 20.12 Million | 7.4 Million | 6.86 Million | 2.67 Million |
| Cost of Revenue | 714 Thousand | 640 Thousand | 3.55 Million | 1.27 Million | 487 Thousand | 866 Thousand |
| Gross Profit | 576 Thousand | 35.95 Million | 16.57 Million | 6.12 Million | 6.38 Million | 1.81 Million |
| Operating Expenses | 22.98 Million | 23.58 Million | 101.5 Million | 24.25 Million | 29.53 Million | 21.93 Million |
| Selling, General and Administrative Expenses | 3.23 Million | 3.41 Million | - | 3.09 Million | 4.91 Million | 4.44 Million |
| Research and Development Expenses | 19.74 Million | 20.16 Million | - | 21.16 Million | 24.62 Million | 19.7 Million |
| Other Expenses | -218 Thousand | -285 Thousand | 313 Thousand | 1.34 Million | -833 Thousand | 25 Thousand |
| Cost and Expenses | 23.69 Million | 24.22 Million | 105.05 Million | 25.53 Million | 29.53 Million | 21.93 Million |
| Operating Income | -22.4 Million | 12.37 Million | -84.92 Million | -18.12 Million | -22.67 Million | -21.47 Million |
| Interest Expense | - | 2000.00 | 317 Thousand | 49 Thousand | -49 Thousand | 97 Thousand |
| Income Tax Expense | - | 596.72 Thousand | 368 Thousand | 164 Thousand | -487 Thousand | 122 Thousand |
| Earnings before Tax | -19.09 Million | 14.38 Million | -81.21 Million | -24.65 Million | -19.06 Million | -18.01 Million |
| Net Income | -19.09 Million | 14.38 Million | -81.58 Million | -24.81 Million | -19.06 Million | -18.01 Million |
| Earnings Per Share Basic | -1.52 | 1.10 | - | -2.51 | -1.73 | -2.18 |
| Earnings Per Share Diluted | -1.52 | 1.10 | - | -2.51 | -1.73 | -2.18 |
| Weighted Average Shares Outstanding | 12.53 Million | 12.53 Million | 9.45 Million | 9.89 Million | 11.03 Million | 8.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.53 Million | 12.59 Million | 9.45 Million | 9.89 Million | 11.03 Million | 8.27 Million |
| Gross Margin | 0.45 | 0.98 | 0.82 | 0.83 | 0.93 | 0.68 |
| EBIT Margin | -16.81 | 0.36 | - | -2.28 | -3.30 | -6.37 |
| Profit Margin | -14.80 | 0.39 | -4.05 | -3.35 | -2.78 | -6.72 |
| EBITDA | -21.69 Million | 13.01 Million | - | -16.85 Million | -22.67 Million | -17.05 Million |
| Earnings Before Tax Margin | -17.37 | 0.34 | -4.22 | -2.45 | -3.30 | -8.01 |
COME
FCF
ANGI
688001
IFA1V
SMBZF